About Jubilant DraxImage

We develop, manufacture and commercialize radiopharmaceuticals used for the diagnosis and treatment of disease. We serve customers and through them patients, globally with high quality and reliable products and services.

Jubilant DraxImage is a subsidiary of Jubilant Pharma

Read more

Latest News and Events

12 May

JDI and CYC Licensing Agreement Update

Jubilant DraxImage and Cyclopharm Terminate Technegas Licensing Agreement Negotiations Read more

03 May

Not all Iodine-131 is created equal

Jubilant DraxImage launches “Not all Iodine-131 is created equal” Campaign Read more

06 Jan

Count On It DRAXIMAGE® MAA 350K Particles Campaign

Jubilant DraxImage launches Count On It DRAXIMAGE® MAA 350K Particles Campaign Read more

03 Dec

USA - Radioactive Iodine in Differentiated Thyroid Cancer; Patient Video

JDI releases a patient video to demystify the role of Radioactive Iodine in the treatment of Differentiated Thyroid Cancer (DTC) Read more